Article Figures & Tables
Figures
Figure 1: Selection of studies for meta-analysis.
Figure 2: Analysis of mortality in selected trials of erythropoietin use in critially ill patients. Note: EPO = erythropoietin, CI = confidence interval.
Figure 3: Mortality sensitivity analysis of studies included in the meta-analysis of erythropoietin use in critically ill patients. Note: CI = confidence interval.
Figure 4: Analysis of transfusion independence among critically ill patients who received erythropoietin or control (placebo or no intervention). EPO = erythropoietin, CI = confidence interval.
Tables
Table 1.
Table 2.
Table 3.
In this issue
Article tools
Respond to this article
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials
Jump to section
Related Articles
Cited By...
- Anemia, Bleeding, and Blood Transfusion in the Intensive Care Unit: Causes, Risks, Costs, and New Strategies
- Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation
- Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response?
- Erythropoietic agents for anemia of critical illness
- Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients
- Corticosteroids and erythropoeitin-receptor agonists
- L'expansion des indications : medecins, attention
- Indication creep: physician beware
- Erythropoietin use in critically ill patients: forest and trees